Publications by authors named "P Calzoni"

Claim this Profile
C
Carriers of Rare Variants Are at High Risk of Life-Threatening COVID-19.
Kristina Zguro, Margherita Baldassarri, Francesca Fava, Giada Beligni, Sergio Daga, Paola Calzoni

Viruses· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy.
L Puccetti, V Sammartano, P Calzoni, F Bacchiarri, A Santoni

Eur Rev Med Pharmacol Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid?
Luca Puccetti, Francesca Bacchiarri, Paola Calzoni, Adele Santoni, Monica Bocchia

Intern Emerg Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid?
Luca Puccetti, Francesca Bacchiarri, Paola Calzoni, Adele Santoni, Monica Bocchia

Intern Emerg Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A collaborative study by the Working Group on Hemostasis and Thrombosis of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) on the interference of haemolysis on five routine blood coagulation tests by evaluation of 269 paired haemolysed/non-haemolysed samples.
Chiara Novelli, Matteo Vidali, Bruno Brando, Benedetto Morelli, Giovanna Andreani, Paola Calzoni

Biochem Med (Zagreb)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis